TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.

Y-J Bang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.